These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26147754)

  • 1. Growth hormone replacement does not increase mortality in patients with childhood-onset growth hormone deficiency.
    Berglund A; Gravholt CH; Olsen MS; Christiansen JS; Stochholm K
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):677-83. PubMed ID: 26147754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.
    Sävendahl L; Maes M; Albertsson-Wikland K; Borgström B; Carel JC; Henrard S; Speybroeck N; Thomas M; Zandwijken G; Hokken-Koelega A
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E213-7. PubMed ID: 22238393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and GH deficiency: a nationwide study.
    Stochholm K; Gravholt CH; Laursen T; Laurberg P; Andersen M; Kristensen LØ; Feldt-Rasmussen U; Christiansen JS; Frydenberg M; Green A
    Eur J Endocrinol; 2007 Jul; 157(1):9-18. PubMed ID: 17609396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study.
    Carel JC; Ecosse E; Landier F; Meguellati-Hakkas D; Kaguelidou F; Rey G; Coste J
    J Clin Endocrinol Metab; 2012 Feb; 97(2):416-25. PubMed ID: 22238382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients.
    Johannsson G; Touraine P; Feldt-Rasmussen U; Pico A; Vila G; Mattsson AF; Carlsson M; Korbonits M; van Beek AP; Wajnrajch MP; Gomez R; Yuen KCJ
    J Clin Endocrinol Metab; 2022 Jun; 107(7):1906-1919. PubMed ID: 35368070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity and GH deficiency: a nationwide study.
    Stochholm K; Laursen T; Green A; Laurberg P; Andersen M; Kristensen LØ; Feldt-Rasmussen U; Christiansen JS; Frydenberg M; Gravholt CH
    Eur J Endocrinol; 2008 Apr; 158(4):447-57. PubMed ID: 18362290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle strength and power, maximum oxygen consumption, and body composition in middle-aged short-stature adults with childhood-onset growth hormone deficiency.
    Sartorio A; Agosti F; De Col A; Mazzilli G; Marazzi N; Busti C; Galli R; Lafortuna CL
    Arch Med Res; 2008 Jan; 39(1):78-83. PubMed ID: 18067999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in prothrombin and activated partial thromboplastin time during replacement therapy with human recombinant growth hormone in growth hormone deficient adults.
    Miljic D; Miljic P; Doknic M; Pekic S; Djurovic M; Colovic M; Popovic V
    Hormones (Athens); 2006; 5(3):187-91. PubMed ID: 16950752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory Committee.
    Taback SP; Dean HJ
    J Clin Endocrinol Metab; 1996 May; 81(5):1693-6. PubMed ID: 8626817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in adults.
    van Bunderen CC; van Nieuwpoort IC; Arwert LI; Heymans MW; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3151-9. PubMed ID: 21849531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and socioeconomic status in adults with childhood onset GH deficiency (GHD) is highly dependent on the primary cause of GHD.
    Stochholm K; Juul S; Christiansen JS; Gravholt CH
    Eur J Endocrinol; 2012 Nov; 167(5):663-70. PubMed ID: 22918302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different long-term response to growth hormone therapy in small- versus appropriate-for-gestational-age children with growth hormone deficiency.
    Meazza C; Pagani S; Pietra B; Tinelli C; Calcaterra V; Bozzola E; Bozzola M
    Horm Res Paediatr; 2013; 79(4):214-9. PubMed ID: 23635718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fracture incidence in GH-deficient patients on complete hormone replacement including GH.
    Holmer H; Svensson J; Rylander L; Johannsson G; Rosén T; Bengtsson BA; Thorén M; Höybye C; Degerblad M; Bramnert M; Hägg E; Engström BE; Ekman B; Thorngren KG; Hagmar L; Erfurth EM
    J Bone Miner Res; 2007 Dec; 22(12):1842-50. PubMed ID: 17725379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.
    Colao A; di Somma C; Cuocolo A; Spinelli L; Tedesco N; Pivonello R; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2001 May; 86(5):1874-81. PubMed ID: 11344175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.